Terms: = Endocrine gland cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
18 results:
1. Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
Colombo C; Ceruti D; De Leo S; Bilo G; Trevisan M; Giancola N; Moneta C; Parati G; Persani L; Fugazzola L
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37097040
[TBL] [Abstract] [Full Text] [Related]
2. Interface assembly of specific recognition gripper wrapping on activated collagen fiber for synergistic capture effect of iodine.
Zhu H; Wang B; Zhu W; Duan T; He G; Wei Y; Sun D; Zhou J
Colloids Surf B Biointerfaces; 2022 Feb; 210():112216. PubMed ID: 34838421
[TBL] [Abstract] [Full Text] [Related]
3. A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice.
Chi Z; Chen L; Huang J; Jiang N; Zheng Q; Huang N; Yang W
Brachytherapy; 2021; 20(1):218-225. PubMed ID: 33158777
[TBL] [Abstract] [Full Text] [Related]
4. PBK, targeted by evi1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
[TBL] [Abstract] [Full Text] [Related]
5. The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human cancer Cell Lines.
Müller L; Radtke A; Decker J; Koch M; Belge G
Anticancer Res; 2017 Nov; 37(11):6341-6345. PubMed ID: 29061818
[TBL] [Abstract] [Full Text] [Related]
6. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
[No Abstract] [Full Text] [Related]
7. Risk Factors of Lymphnode Metastasis in Patients with Thyroid Papillary Carcinoma Associated with Graves Disease.
Xie Y; Liu YW; Wang MY; Wang WZ; Liu HF; Li XY; Gao WS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):554-558. PubMed ID: 27825413
[TBL] [Abstract] [Full Text] [Related]
8. Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer.
Lambrechts S; Smeets D; Moisse M; Braicu EI; Vanderstichele A; Zhao H; Van Nieuwenhuysen E; Berns E; Sehouli J; Zeillinger R; Darb-Esfahani S; Cacsire Castillo-Tong D; Lambrechts D; Vergote I
Eur J Cancer; 2016 Jan; 53():51-64. PubMed ID: 26693899
[TBL] [Abstract] [Full Text] [Related]
9. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract] [Full Text] [Related]
10. SUMO1 negatively regulates the transcriptional activity of evi1 and significantly increases its co-localization with evi1 after treatment with arsenic trioxide.
Singh S; Pradhan AK; Chakraborty S
Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
[TBL] [Abstract] [Full Text] [Related]
11. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
Smith DM; Patel S; Raffoul F; Haller E; Mills GB; Nanjundan M
Cell Death Differ; 2010 Dec; 17(12):1867-81. PubMed ID: 20508647
[TBL] [Abstract] [Full Text] [Related]
12. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM
Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105
[TBL] [Abstract] [Full Text] [Related]
13. Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.
Osterberg L; Levan K; Partheen K; Delle U; Olsson B; Sundfeldt K; Horvath G
BMC Cancer; 2009 Oct; 9():368. PubMed ID: 19835627
[TBL] [Abstract] [Full Text] [Related]
14. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
Shi Y; Zou M; Baitei EY; Alzahrani AS; Parhar RS; Al-Makhalafi Z; Al-Mohanna FA
Cancer Gene Ther; 2008 Feb; 15(2):101-7. PubMed ID: 18197164
[TBL] [Abstract] [Full Text] [Related]
15. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
[TBL] [Abstract] [Full Text] [Related]
16. Percutaneous ethanol injection of autonomously functioning thyroid nodule.
Solbiati L; Ierace T; Cova L; Dellanoce M; Marelli P
Rays; 1999; 24(2):348-57. PubMed ID: 10509136
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and complications of the Gianturco-Z tracheobronchial stent for malignant airway stenosis.
Nakajima Y; Kurihara Y; Niimi H; Konno S; Ishikawa T; Osada H; Kojima H
Cardiovasc Intervent Radiol; 1999; 22(4):287-92. PubMed ID: 10415217
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract] [Full Text] [Related]
